Unlearn.AI vs Scaleway
Side-by-side comparison of AI visibility scores, market position, and capabilities
Unlearn.AI raised $50M+ for its digital twin technology that creates AI-generated control arms for clinical trials, reducing placebo group size and accelerating drug development timelines.
About
Unlearn.AI generates digital twins of clinical trial patients — AI models trained on historical trial data that predict how a specific patient would have responded as a placebo control. By supplementing small placebo control groups with these digital controls, pharmaceutical companies can run trials with fewer placebo patients (or none at all), reducing participant burden, trial costs, and development timelines without sacrificing statistical validity.
Scaleway is a French cloud provider under Iliad Group with ~€150M estimated revenue. Focused on European data sovereignty and GPU cloud for AI. HQ: Paris. Founded 1999.
About
Scaleway is a French cloud computing provider and subsidiary of Iliad Group, the telecommunications and technology conglomerate founded by billionaire Xavier Niel. Originally launched as Online.net in 1999 and rebranded as Scaleway in 2015, the company has grown into one of Europe's leading independent cloud providers, positioning itself as the European alternative to US hyperscalers for GDPR-sensitive workloads.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.